Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Akiko Yoshimatsu"'
Autor:
Yuichi Yasutake, Chihiro Yasue, Soichiro Miura, Kenichi Yoshikawa, Koji Maruta, Takeshi Takajo, Ryota Hokari, Akiko Yoshimatsu, Kazuki Horiuchi, Chikako Watanabe, Shigeaki Nagao, Kengo Tomita, Shunsuke Komoto, Hirokazu Sato
Publikováno v:
Progress of Digestive Endoscopy. 86:74-78
Publikováno v:
Arzneimittelforschung. 59:248-253
Granulocyte colony-stimulating factor (G-CSF) is known to mobilize stem cells to various organs and that it participates in tissue regeneration. Effect of the recombinant human G-CSF nartograstim (CAS 134088-74-7) was tested on elastase-induced emphy
Autor:
Yukiko Doi, Akiko Yoshimatsu, Shigenori Watanabe, Takao Shimazoe, Takako Fukumoto, Ikumi Arai
Publikováno v:
Japanese Journal of Pharmacology. 89:85-88
The role of metabotropic glutamate receptor (mGluR) on dopamine overflow from the striatum was studied in methamphetamine (MAP)-sensitized rats. The increase of dopamine release by MAP was significantly inhibited by perfusion of a mGluR antagonist R,
Publikováno v:
Japanese Journal of Pharmacology. 84:78-81
Adenosine was intraperitoneally (i.p.) injected to Wistar rats every 3 days with a total of 5 administrations. After a 7-day withdrawal, the animals were challenged with methamphetamine (0.5 mg/kg, i.p.). The effect of methamphetamine on locomotor ac
Autor:
Ikumi Arai, Shigenobu Shibata, Shigenori Watanabe, Akiko Yoshimatsu, Hirotaka Inoue, Takao Shimazoe
Publikováno v:
Japanese Journal of Pharmacology. 78:105-108
We examined the influence of ischemia on methamphetamine (MAP)-induced behavioral sensitization and enhancement of dopamine (DA) release. After the recovery period of the ischemia operation, rats were treated with MAP (1 mg/kg, i.p.) once daily for 6
Autor:
Hiroshi Okumura, Michio Ichimura, Junko Irie, Yuji Nomoto, Yasuo Onoda, Haruki Takai, Akiko Yoshimatsu, Tetsuji Ohno, Ryo Hirose
Publikováno v:
European journal of pharmacology. 431(1)
The effects of KF31327 (3-ethyl-8-[2-(4-hydroxymethylpiperidino)benzylamino]-2,3-dihydro-1H-imidazo[4,5-g]quinazoline-2-thione dihydrochloride) on phosphodiesterase 5 (cyclic GMP-specific phosphodiesterase) activity and platelet aggregation were inve
Autor:
Takahide Shuto, Shigenori Watanabe, Takako Fukumoto, Takao Shimazoe, Yukiko Doi, Atsuko Kawashimo, Akiko Yoshimatsu
Publikováno v:
Japanese journal of pharmacology. 86(2)
We report here both adenosine A1- and A2A-receptor agonists inhibit the expression of methamphetamine (MAP)-induced behavioral sensitization in rats. Animals were treated with MAP (1.0 mg /kg, i.p.) every 3 days with a total of 5 administrations. The
Publikováno v:
European journal of pharmacology. 388(3)
We studied the effects of adenosine A(1) and A(2A) receptor agonists on the expression and development of methamphetamine-induced sensitization in rats. When animals were treated with the adenosine A(1) receptor agonist, N(6)-cyclohexyladenosine (CHA
Autor:
Akiko Yoshimatsu, Shigenori Watanabe, Shigenobu Shibata, Takao Shimazoe, Hirotaka Inoue, Ikumi Arai
Publikováno v:
Japanese journal of pharmacology. 73(3)
We studied the roles of metabotropic glutamate receptors in methamphetamine (MAP)-induced sensitization of dopamine (DA) release from striatal slices. Rats were first treated with MAP (1 mg/kg, i.p.) once daily for 6 consecutive days. After a 6-day w
Autor:
Akiko Yoshimatsu, Shigenobu Shibata, Ikumi Arai, Shigenori Watanabe, Hirotaka Inoue, Takao Shimazoe
Publikováno v:
Brain research. 729(2)
An intracerebral microdialysis technique was applied to study the effect of metabotropic glutamate receptor (mGluR) agonist on dopamine release in the striatum of methamphetamine (MAP)-sensitized rats. Rats were treated with MAP (1 mg/kg, i.p.) once